Factors influencing long-term survival in patients on chronic dialysis

Clinical and Experimental Nephrology

Volumn 8, Issue 2, 2004, Pages 89-97

  Iseki, Kunitoshi ^a,b   Shinzato, Takahiro ^b   Nagura, Yuji ^b   Akiba, Takashi ^b  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^b Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

Author keywords

Comorbid condition; Hemodialysis; Kt V; Malnutrition; Survival

Indexed keywords

COMORBIDITY; DIABETES MELLITUS; DIALYSIS; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEMALE; HEMODIALYSIS; HUMAN; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; REGISTER; REVIEW; SOCIOECONOMICS; SURVIVAL TIME;

EID: 3142592312     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0285-z     Document Type: Review

References (86)

1. Odaka M. Mortality in chronic dialysis patients in Japan. Am J Kidney Dis 1990;15:410-13.
2. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gavlin DS. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan. Am J Kidney Dis 1990;15:451-7.
3. Teraoka S, Toma H, Nihei H, Ota K, Babazono T, Ishikawa I, et al. Current status of renal replacement therapy in Japan. Am J Kidney Dis 1995;25:151-64.
4. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, et al. Survival in long-term hemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1996;11:2139-42.
5. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, et al. Current status of renal replacement therapy in Japan: results of the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1996;11:2143-50.
6. Shinzato T, Nakai S, Akiba T, Yamagami S, Yamazaki C, Kitaoka T, et al. Report on the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int 1999;55:700-12.
7. Akiba T, Nakai S, Shinzato T, Yamazaki C, Kitaoka T, Kubo K, et al. Why has the gross mortality of dialysis patients increased in Japan? Kidney Int 2000;57(Suppl 74):S60-5.
8. Nakai S, Shinzato T, Sanaka T, Kikuchi K, Kitaoka T, Shinoda T, et al. The current state of chronic dialysis treatment in Japan (as of December 31, 2001). J Jpn Soc Dial Ther 2003;36:1-31.
9. Charra B, Calemand E, Ruffet M, Chazot C, Terrat JC, Vanel T, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-91.
10. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998;32:720-4.
11. Eknovan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-19.
12. Blake PG. Nephrology Forum-adequacy of dialysis revisited. Kidney Int 2003;63:1587-99.
13. Locatelli F, Marcelli D, Conte F. Dialysis patient outcomes in Europe vs the USA. Why do Europeans live longer? Nephrol Dial Transplant 1997;12:1816-19.
14. Friedman EA. Controversy, international comparisons of survival on dialysis: are they reliable? Hemodialysis Int 2003;7:59-66.
15. Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LYC, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999;55:2515-23.
16. Frankenfield DL, Ramirez SPB, McClellan WM, Frederick PR, Rocco MV. Differences in intermediate outcomes for Asian and non-Asian adult hemodialysis patients in the United States. Kidney Int 2003;64:623-31.
17. Pei YPC, Greenwood CMT, Chery AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int 2000;58:1293-9.
18. Breyer-Lewis J. Risky business (editorial). Kidney Int 1999;55:2528-9.
19. Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 1993;43:404-9.
20. Iseki K, Tozawa M, Iseki C, Takishita S, Ogawa Y. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int 2002;61:668-75.
21. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996;50:550-6.
22. Vanholder R, Smet RD, Glorieux G, Dhondt A. Survival of hemodialysis patients and uremic toxin removal. Artif Organs 2003;27:218-23.
23. Parker TF III, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 1996;49:551-6.
24. Iseki K, Nishime K, Uehara H, Osawa A, Fukiyama K. Effect of renal diseases and comorbid conditions on survival in chronic dialysis patients. Nephron 1994;68:80-6.
25. Iseki K, Tozawa M, Takishita S. Effect of the duration of dialysis on survival in a cohort of chronic hemodialysis patients. Nephrol Dial Transplant 2003;18:782-7.
26. Iseki K, Fukiyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 1996;50:1672-5.
27. Tozawa M, Iseki K, Iseki C, Takishita S. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 2002;61:717-26.
28. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115-19.
29. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 1997;51:1212-17.
30. Iseki K, Yamazato M, Tozawa M, Takishita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 2002;61:1887-93.
31. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999;14:1956-60.
32. Matsuoka M, Iseki K, Fujimoto N, Tamashiro M, Higa N, Touma T, et al. Significance of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004;8:54-8.
33. Iseki K, Fukiyama K, and the Okinawa Dialysis Study (OKIDS) Group. Clinical demographics and long-term prognosis after stroke in patients on chronic hemodialysis. Nephrol Dial Transplant 2000;15:1808-13.
34. Iseki K, Fukiyama K, for the Okinawa Dialysis Study Group: Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. Am J Kidney Dis 2000;36:820-5.
35. Iseki K, Osawa A, Fukiyama K. Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis 1993;22:308-13.
36. Iseki K, Uehara H, Nishime K, Tokuyama K, Yoshihara K, Kinjo K, et al. Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. Am J Kidney Dis 1996;28:541-8.
37. Iseki K, Kimura Y, Wakugami K, Okumura K, Muratani H, Ikemiya Y, et al. Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res 2000;23:143-9.
38. Iseki K, Wakugami K, Maehara A, Tozawa M, Muratani H, Fukiyama K. Long-term survival of chronic dialysis patients in comparison to that of stroke and acute myocardial infarction patients. Clin Exp Nephrol 2001;5:109-13.
39. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, et al. Mortality risk factors in patients treated by chronic hemodialysis: report of the Diaphane Collaborative Study. Nephron 1982;31:103-10.
40. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-82.
41. Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002;62:2238-45.
42. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001;21:280-8.
43. Vertes V, Cangiano L, Berman LB, Gould A. Hypertension in end-stage renal disease. N Engl J Med 1969;280:978-81.
44. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992;19:453-9.
45. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease; what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998;32:853-906.
46. Agarwal R. Assessment of blood pressure in hemodialysis patients. Semin Dial 2002;15:299-304.
47. Tozawa M, Iseki K, Fukiyama K. Hypertension in dialysis patients: a cross-sectional analysis. Jpn J Nephrol 1996;38:129-35.
48. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003;64:1472-9.
49. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.
50. Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O'Shea S, Owen WF Jr, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant 2003;18:1167-73.
51. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805.
52. Schaubel DE, Fenton SSA. Trends in mortality rates on hemodialysis in Canada, 1981-1997. Kidney Int 2000;57(Suppl 74):S66-S73.
53. Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, et al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003;63:323-30.
54. Reddan D, Klassen P, Frankenfield DL, Szczech L, Schwab S, Coladonato J, et al. National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol 2002;13:2117-24.
55. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 2003;63:1908-14.
56. Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, et al. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int 2003;64:254-62.
57. Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002;62:199-207.
58. Knight EL, Ofsthun N, Teng M, Lazarus JM, Curhan GC. The association between mental health, physical function, and hemodialysis mortality. Kidney Int 2003;63:1843-51.
59. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, et al. Switch from conventional high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-1.
60. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
61. Salahudeen AK. Is it really good to be fat on dialysis? Nephrol Dial Transplant 2003;18:1248-52.
62. Kaizu Y, Tsunega Y, Yoneyama T, Sakao T, Hibi I, Miyaji K, et al. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol 1998;50:44-50.
63. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997;12:884-8.
64. Iseki K, Iseki C, Itoh K, Uezono K, Sanefuji M, Ikemiya Y, et al. Urinary excretion of sodium and potassium in a screened cohort in Okinawa, Japan. Hypertens Res 2002;25:731-6.
65. Foley RN, Herzog CA, Collins AJ, United States Renal Data System. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Wave 3 and 4 Study. Kidney Int 2002;62:1784-90.
66. Tozawa M, Iseki K, Iseki C, Oshiro S, Higashiuesato Y, Yamazato M, et al. Analysis of drug prescriptions in patients on chronic hemodialysis. Nephrol Dial Transplant 2002;17:1819-24.
67. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83.
68. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 2001;38:64-9.
69. Chertow GM, Burke SK, Raggi P, for the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aoric calcification in hemodialysis patients. Kidney Int 2002;62:245-52.
70. Ganesh SK, Stack AG, Levin NW, Hulbert-Searon T, Port FK. Association of elevated serum PO4, Ca × PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12:2131-8.
71. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus MJ, Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003;349:446-56.
72. Shaldon S. Unanswered questions pertaining to dialysis adequacy in 1992. Kidney Int 1993;41:S274-7.
73. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001;37:276-86.
74. Obrador GT, Pereira BJG. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with renal failure. Am J Kidney Dis 1998;31:398-17.
75. Jungers P, Massy ZA, Hguyen-Khoa T, Choukroun G, Robino C, Fakhouri F, et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 2001;16:2357-64.
76. Iseki K for the Okinawa Dialysis Study (OKIDS) Group: Analysis of referral pattern and survival in chronic dialysis patients in Okinawa, Japan (1993-1997). Clin Exp Nephrol 2002;6:43-8.
77. Hidai H. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management. Kidney Int 2000;58:363-73.
78. Shiohira Y, Iseki K, Kowatari T, Uehara H, Yoshihara K, Nishime K, et al. A community-based evaluation of the effect of renal transplantation on survival in patients with renal-replacement therapy. Jpn J Nephrol 1996;38:449-54.
79. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.
80. Iseki K, Wakugami K, Maehara A, Tozawa M, Muratani H, Fukiyama K. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger. Am J Kidney Dis 2001;38:1235-9.
81. Ross S, Dong E, Gordon M, Connelly J, Kvasz M, Iyengar M, et al. Meta-analysis of outcome studies in end-stage renal disease. Kidney Int 57;2000;(Suppl 74):S28-38.
82. Usami T, Koyama K, Takeuchi O, Morozumi K, Kimura G. Regional variation in the incidence of end-stage renal failure in Japan. JAMA 2000;284:2622-4.
83. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2003;13:2125-32.
84. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002;13(Suppl 1):S37-S40.
85. Schieppati A, Perico N, Remuzzi G. Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries. Nephrol Dial Transplant 2003;18:858-9.
86. Schieppati A, Perico N, Remuzzi G. Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries. Kidney Int 2003;63:1948-50.